Reduced high-density lipoprotein cholesterol in patients receiving rosiglitazone and fenofibrate.
Venero
Carmelo V
CV
Thompson
Paul D
PD
Fernandez
Antonio B
AB
D000368:Aged; D008076:Cholesterol, HDL / Q000097:blood*; D004359:Drug Therapy, Combination; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D008076:Cholesterol, HDL; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D011345:Fenofibrate